Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)
Good calls: Vertex, InterMune, Chelsea, Galena, Exact Sciences. The bad calls: Avanir, Amarin, Exelixis and the bursting biotech stock bubble.
Jim Cramer on the Stock Market: You Have to Love Biotech
In this era of turmoil, investors can take comfort in this sector.
Energy Stocks Shake Off Plunging Oil Prices to Push the Dow to New Highs
Oil prices backtrack from Monday's bounce, but energy stocks shake it off. Instead, the sector gains more than 1% after several weeks of punishing losses.
Stocks Hover Near Highs as Oil Backtracks From Monday Bounce
Oil is back in the spotlight Tuesday as prices backtrack from Monday's bounce and move lower again.
Stocks Gain as Construction Spending Expands, Global Stimulus Talk Heats Up
U.S. stocks book modest gains on Tuesday morning as domestic construction spending expands.
Disney Fans Angry, Excited About New Guardians of the Galaxy Ride
The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.
Aurora Cannabis Slashing Weed Capacity in Profitability Push
Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.
Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion
Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.